OssDsign Announces New Partnerships for Commercialisation of Its Novel Medical Implants in Europe
UPPSALA, SWEDEN, January 12, 2017 (Newswire.com) - OssDsign AB, a Swedish designer, manufacturer and distributor of next generation implants for cranial and facial reconstruction, today announced it has entered new commercial partnerships covering distribution of its products in Italy, Spain, Switzerland, Austria and The Netherlands.
OssDsign‘s lead products – OSSDSIGN® Cranial and OSSDSIGN® Facial – are already on sale in Germany, the UK and the Nordic region, as well as selected non-European markets including Singapore and Israel. The Company is preparing for its first product launch in the US, which is anticipated during the first quarter of 2017, and is undertaking regulatory and commercial activities in Japan.
We are very pleased to increase our commercial footprint in Europe as we work to become the leading provider of regenerative implants for cranial and facial reconstruction. We now have experienced and well-motivated teams in place to execute our European strategy and bring OssDsign products closer to the surgeons and patients who will ultimately benefit from them.
Anders Lundqvist , CEO, OssDsign AB
Anders Lundqvist, CEO of OssDsign, said, “We are very pleased to increase our commercial footprint in Europe as we work to become the leading provider of regenerative implants for cranial and facial reconstruction. We now have experienced and well-motivated teams in place to execute our European strategy and bring OssDsign products closer to the surgeons and patients who will ultimately benefit from them.”
About OssDsign
OssDsign commercial strategy is focused on building sales of its innovative products through a combination of internal sales organisation and distribution partnerships, and the Company raised SEK 93 million to support these ambitions in November 2015.
Source: OssDsign AB
